Pelabresib (30-60 mg/kg; oral administration; for 28 days; MV-4-11 mouse xenograft model) treatment results in substantial suppression of tumor growth over the time period examined (41%, 80%, and 74% tumor growth inhibition, respectively), without any significant body weight loss in the animals[1].
| Animal Model: | MV-4-11 mouse xenograft model[1] |
| Dosage: | 30 mg/kg once daily, 30 mg/kg twice daily, or 60 mg/kg once daily |
| Administration: | Oral administration; for 28 days |
| Result: | Suppressed of tumor growth, without any significant body weight loss in the animals.
|